45.861 Haptoglobin precursor P00738 Metabolism Type 2 DM-NP Downregulated DIGE followed MALD1-TOF-MS [29 ] 46,707
𝛼
1-antitrypsinP01009 Defense response Type 2 DM-NP Upregulated DIGE followed LC/MS/MS peptide analysis [19 ] 51,643
𝛼
1-microglobulin/bikunin precursorP02790 Transport Type 2 DM-NP Downregulated DIGE followed LC/MS/MS peptide analysis [19 ] 51,643 Hemopexin P02790 Defense response Type 2 DM-NP Upregulated DIGE followed LC/MS/MS peptide analysis [19 ] 52,964 Vitamin D-binding protein P02774 Transport Type 2 DM-NP Upregulated DIGE followed LC/MS/MS peptide analysis [19 ] 54,239
𝛼
1B- GlycoproteinP04217 Function not assigned Type 2 DM-NP Upregulated DIGE followed LC/MS/MS peptide analysis [19 ] 71,317 Albumin P02768 Transport Type 2 DM Upregulated Two-Dimensional Liquid Chromatography followed by MALDI [20 ] 71,317 Serum albumin precursor P02768 Transport Type 2 DM-NP Upregulated DIGE followed MALDI-TOF-MS [29 ] 72,451 Uromodulin precursor P07911 Defense responsc Type 2 DM-NP Downregulated DIGE followed MALDI-TOF-MS [29 ] 72,984 Kininogen precursor P01042 Defense response Type 2 OM-NP Upregulated DIGE followed MALDI-TOF-MS [29 ] 97.853 Epithelial-cadherin P12830 Cell adhesion Type 2 DM Upregulated Two-Dimensional Liquid Chromatography followed by MALDI [20 ] 97,853 Epithelial-cadherin P12830 Cell adhesion Type 2 DM-NP Upregulated DIGE followed MALDI-TOF-MS [29 ] 2,049
Collagen
𝛼
-1 (I) chain precursor
P02452
Structural Component
Type 2 DM-NP and NP
Upregulated
MALDl/TOF/TOF
[31 ] 2,063 Collagen alpha-1 (III) chain P02461 Structural Component Type 2 DM Downregulated with respect to type i dm CZE-MS [28 ] 2,192 Collagen
𝛼
-1(I) chain P02452 Structural Component Type 2 DM-NP Downregulated CZE coupled with ES1 mass spectrometry [25 ] 2,192 Collagen alpha-1(I) chain P02452 Structural Component Type 2 DM Downregulated with respect to type 1dm CZE-MS [28 ] 2,339 Collagen alpha-1(I) chain P02452 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 2,377 Collagen
𝛼
-1(I) chain [227 to 250] P02452 Structural Component Type 2 DM-NP Downregulated CZE coupled with ESI mass spectrometry [25 ] 2,430 Collagen alpha-1(I) chain P02452 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 2,487 Collagen alpha-1(I) chain P02452 Structural Component Type 2 DM Downregulated with respect to type 1dm CZE-MS [28 ] 2,687 Collagen alpha-1(I) chain P02452 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 3,092 Collagen alpha-1(I) chain P02452 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 3,617 Collagen alpha-2(I) chain P08123 Structural Component Type 2 DM Downregulated with respect to type i dm CZE-MS [28 ] 3,802 Collagen alpha-2(I) chain P08123 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 11,773 Ig Kappa Chain C region P01834 Defense response Type 2 DM-NP Upregulated DIGE followed MALDI-TOF-MS [29 ] 11,774
𝛽
2-microglobulinP61769 Defense response Type 2 DM-NP with Proteinuria Upregulated anion exchange, reversed-phase fractionation, gel electrophoresis and SELDI-TOF MS [18 ] 13,234 Calgranulin B P06702 Defense response Type 2 DM-NP Upregulated Using DIGE followed LC/MS/MS peptide analysis [19 ] 2,049 Collagen
𝛼
-1 (I) chain precursor P02452 Structural Component Type 2 DM-NP and NP Upregulated MALD/TOF/TOF [31 ] 2,063 Collagen alpha-1 (III) chain P02461 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 2,192 Collagen
𝛼
-1(I) chain P02452 Structural Component Type 2 DM-NP Downregulated CZE coupled with ESI mass spectrometry [25 ] 2,192 Collagen alpha-1 (I) chain P02452 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 2,339 Collagen alpha-1 (I) chain P02452 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 2,377 Collagen
𝛼
-1 (I) chain [227 to 250] P02452 Structural Conioonent Type 2 DM-NP Downregulated CZE coupled with ESI mass spectrometry [25 ] 2,430 Collagen alpha-1 (I) chain P02452 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 2,487 Collagen alpha-1 (I) chain P02452 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 2,687 Collagen alpha-1 (I) chain P02452 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 3,092 Collagen alpha-1 (I) chain P02452 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 3,617 Collagen alpha-2(I) chain P08123 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 3,802 Collagen alpha-2(l) chain P08123 Structural Component Type 2 DM Downregulated with respect to type 1 dm CZE-MS [28 ] 11,773 Ig Kappa Chain C region P01834 Defense response Type 2 DM-NP Upregulated DIGE followed MALDI-TOF-MS [29 ] 11,774
𝛽
2-microglobulinP61769 Defense response Type 2 DM- NP with Proteinuria Upregulated anion exchange, reversed-phase fractionation, gel electrophoresis and SELDI-TOF MS [18 ] 13,234 Calgranulin B P06702 Defense response Type 2 DM-NP Upregulated Using DIGE followed LC/MS/MS peptide analysis [19 ] 45,861
Haptoglobin precursor
P00738
Metabolism
Type 2 DM-NP
Downregulated
DIGE followed MALDI-TOF-MS
[29 ] 46,707
𝛼
1-antitrypsinP01009 Defense response Type 2 DM-NP Upregulated DIGE followed LC/MS/MS peptide analysis [19 ] 51,643
𝛼
1-microglobulin/bikunin precursorP02790 Transport Type 2 DM-NP Downregulated DIGE followed LC/MS/MS peptide analysis [19 ] 51,643 Hemopexin P02790 Defense response Type 2 DM-NP Upregulated DIGE followed LC/MS/MS peptide analysis [19 ] 52,964 Vitamin D-binding protein P02774 Transport Type 2 DM-NP Upregulated DIGE followed LC/MS/MS peptide analysis [19 ] 54,239
𝛼
1B-GlycoproteinP04217 Function not assigned Type 2 DM-NP Upregulated DIGE followed LC/MS/MS peptide analysis [19 ] 71,317 Albumin P02768 Transport Type 2 DM Upregulated Two-Dimensional Liquid Chromatography followed by MALDI [20 ] 71,317 Serum albumin precursor P02768 Transport Type 2 DM-NP Upregulated DIGE followed MALDI-TOF-MS [29 ] 72,451 Uromodulin precursor P07911 Defense response Type 2 DM-NP Downregulated DIGE followed MALDI-TOF-MS [29 ] 72,984 Kininogen precursor P01042 Defense response Type 2 DM-NP Upregulated DIGE followed MALDI-TOF-MS [29 ] 97,853 Epithelial-cadherin P12830 Cell adhesion Type 2 DM Upregulated Two-Dimensional Liquid Chromatography followed by MALDI [20 ] 97,853 Epithelial-cadherin P12830 Cell adhesion Type 2 DM-NP Upregulated DIGE followed MALDI-TOF-MS [29 ]